scholarly journals ASSOCIATIONS OF RECENT WEIGHT CHANGES WITH TOTAL HEALTH CARE COSTS AMONG OLDER WOMEN

2016 ◽  
Vol 56 (Suppl_3) ◽  
pp. 217-217
SLEEP ◽  
2019 ◽  
Vol 43 (2) ◽  
Author(s):  
Kristine E Ensrud ◽  
Allyson M Kats ◽  
John T Schousboe ◽  
Lisa Langsetmo ◽  
Tien N Vo ◽  
...  

Abstract Study Objectives Determine the association of poor multidimensional sleep health with health-care costs and utilization. Methods We linked 1,459 community-dwelling women (mean age 83.6 years) participating in the Study of Osteoporotic Fractures Year 16 visit (2002–2004) with their Medicare claims. Five dimensions of sleep health (satisfaction, daytime sleepiness, timing, latency, and duration) were assessed by self-report. The number of impaired dimensions was expressed as a score (range 0–5). Total direct health-care costs and utilization were ascertained during the subsequent 36 months. Results Mean (SD) total health-care costs/year (2017 dollars) increased in a graded manner across the sleep health score ranging from $10,745 ($15,795) among women with no impairment to up to $15,332 ($22,810) in women with impairment in three to five dimensions (p = 0.01). After adjustment for age, race, and enrollment site, women with impairment in three to five dimensions vs. no impairment had greater mean total costs (cost ratio [CR] 1.34 [95% CI = 1.13 to 1.60]) and appeared to be at higher risk of hospitalization (odds ratio (OR) 1.31 [95% CI = 0.96 to 1.81]). After further accounting for number of medical conditions, functional limitations, and depressive symptoms, impairment in three to five sleep health dimensions was not associated with total costs (CR 1.02 [95% CI = 0.86 to 1.22]) or hospitalization (OR 0.91 [95% CI = 0.65 to 1.28]). Poor multidimensional sleep health was not related to outpatient costs or risk of skilled nursing facility stay. Conclusions Older women with poor sleep health have higher subsequent total health-care costs largely attributable to their greater burden of medical conditions, functional limitations, and depressive symptoms.


2018 ◽  
Vol 2 (suppl_1) ◽  
pp. 368-368
Author(s):  
J T Schousboe ◽  
T Vo ◽  
L Langsetmo ◽  
S Diem ◽  
K E Ensrud

PLoS ONE ◽  
2018 ◽  
Vol 13 (1) ◽  
pp. e0191642 ◽  
Author(s):  
John T. Schousboe ◽  
Allyson M. Kats ◽  
Lisa Langsetmo ◽  
Brent C. Taylor ◽  
Tien N. Vo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document